Mainstreaming Reproductive Genetic Innovation
Four potential avenues for structuring a societal discourse on reproductive genetic innovation in the U.S.

Four potential avenues for structuring a societal discourse on reproductive genetic innovation in the U.S.

The future of public health in an “RNA world” is on trial in a trade secrecy dispute worth $950 million.

Statutes of limitation present a significant hurdle for plaintiffs experiencing harms from COVID-19 infection.

COVID-19 vaccine manufacturers refusing to share samples may be the latest example of the tragedy of the “anticommons” in biomedical research.

The Supreme Court seems poised to say that the existence of a secular medical exemption to vaccine mandates means a state must offer a religious exemption.

But in the crisis, / immunities rained down, / Tossed freely around like candy at a 4th of July parade

Inefficiencies in negotiating vaccine procurement agreements during COVID-19 could have been attenuated with greater legal preparedness.

There are two key reasons why no-fault compensation is preferable to the regular torts system for handling claims of vaccine harms.

Torts scholars reflect on questions surrounding whether and how entities might be held liable for the harms associated with SARS-CoV-2 infection.
